Login

Here's a preview of our upcoming interview with Ko Yun Hung, Managing Director of ACE Market-bound SNS Network Technology. 00:10:00

Share On Facebook Share On Twitter

SNS Network Technology Berhad's CEO is Yun Hung Ko

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
CEO of Logan Energy, Discusses the Potential of SEA Fuel in Advancing Sustainable Energy Solutions | Bill Ireland, CEO, Logan Energy Corp.
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss quarterly results, the lending environment, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Rob Wiesenthal, CEO of Blade Air Mobility, featured on "Mad Money" to discuss investment opportunities, sign up for CNBC Investing to learn more.|Rob Wiesenthal, CEO of Blade Air Mobility
00:10:00
Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies.
00:10:00
Inside Jane Street: Hospitality Team Insights with Simone
00:10:00
Empowering Youth Through Perspective: A Visionary Dialogue on Leadership and Africa's Future | Sim Tshabalala, CEO, Standard Bank.
00:10:00
Contribute to the development of innovative therapies for patients without existing or effective treatment|Cyrille Tupin,CEO,Cerenis Therapeutics Holding
00:10:00
Group Philippines includes Alfredo Pascual, CEO of the Institute of Corporate Directors and Independent Director of SM Investments Corp., and Jet Pampolina.|Kevin Andrew L.Tan currently works at Alliance Global Group, Inc., as Vice Chairman & Chief Execut
00:10:00
Helium One: Exploring World's Largest Undiscovered Helium Resource
00:10:00
Deciphering the DeClout Blueprint: Navigating the Path to Success | Vesmond Wong , CEO of DeClout Ltd
00:10:00
When and Why to Consider a Roth Conversion: Evaluating the Benefits and Drawbacks | Sarah Kang, Certified Financial Planner of UAK Diversified Wealth Advisors
00:10:00
Leading Plancorp Through Growth and Succession | Jeff Buckner, Chairman, Plancorp

© 2017 - Neuhu+